|
|
|
|
|
by checkoutmygenes
5695 days ago
|
|
> Direct to consumer sales are dead/dying at the hands of the FDA. Not true - such rumors have been greatly exaggerated. >What do you have to offer that say, Counsyl doesn't? At the moment:
Access to your whole genotype and a curated set of the published literature, rather than a narrow carrier screening.
Deep ancestry analysis & finding long-lost cousins.
A commitment to advancing the science of genetics. As the database grows, the insights we generate create more value for the end-user. http://tinyurl.com/246mw46 In the future:
There's lots of opportunity - come talk to us about it. >How do you avoid a war to the realm of being a commodity? genotyping is becoming commoditized, the interpretation of the A's, C's, G's and T's is not. We're in a sweet spot where rapidly falling costs:
- let us offer our service at a lower cost to a broader market
- improve the rates of discovery & create a more valuable interpretation
We have an economy of scale which will allow us to:
- negotiate lower costs
- have a bigger database of potential relatives to meet
- better interpret the meaning individual's genetics |
|